Sectors
CPIX
Cumberland Pharmaceuticals Inc.
3.11
2 x 2.23
2 x 3.60
bid
ask
-
0.03
0.96%
2 @ 04:00 PM
3.11 +0.00 (0.00%)
| Ytd | -21.86% | |
| 1y | -25.06% |
3.10
day range
3.20
1.85
52 week range
6.27
| Open | 3.18 | Prev Close | 3.14 | Low | 3.10 | High | 3.20 | Mkt Cap | 46.52M |
| Vol | 16.95K | Avg Vol | 139.41K | EPS | -0.19 | P/E | N/A | Forward P/E | 16.07 |
| Beta | 0.22 | Short Ratio | 0.92 | Inst. Own | 14.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 3.56 | 200-d Avg | 3.35 | 1yr Est | 8.50 |
| Income Statement | |||
| Total Revenue | 13.68M | ||
| Revenues (USD) | 13.68M | ||
| Cost of Revenue | 2.24M | ||
| Gross Profit | 11.44M | ||
| Operating Expenses | 12.81M | ||
| Research and Development Expense | 1.55M | ||
| Selling, General and Administrative Expense | 10.25M | ||
| Operating Income | -1.37M | ||
| Interest Expense | 112.94K | ||
| Income Tax Expense | 23.25K | ||
| Net Income | -1.41M | ||
| Net Income Common Stock | -1.41M | ||
| Net Income Common Stock (USD) | -1.41M | ||
| Consolidated Income | -1.43M | ||
| Net Income to Non-Controlling Interests | -16.95K | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -1.28M | ||
| Earning Before Interest & Taxes (USD) | -1.28M | ||
| Weighted Average Shares | 14.56M | ||
| Weighted Average Shares Diluted | 14.56M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.44M | ||
| Cash and Equivalents (USD) | 11.44M | ||
| Investments | 3.99M | ||
| Investments Non-Current | 3.99M | ||
| Trade and Non-Trade Receivables | 16.94M | ||
| Current Assets | 37.06M | ||
| Property, Plant & Equipment Net | 8.61M | ||
| Total Assets | 76.82M | ||
| Debt Current | 5.54M | ||
| Total Debt | 15.25M | ||
| Current Liabilities | 36.74M | ||
| Debt Non-Current | 9.71M | ||
| Total Liabilities | 52.28M | ||
| Accumulated Retained Earnings (Deficit) | -26.80M | ||
| Shareholders Equity | 24.88M | ||
| Shareholders Equity (USD) | 24.88M | ||
| Assets Non-Current | 39.76M | ||
| Total Debt (USD) | 15.25M | ||
| Goodwill and Intangible Assets | 14.94M | ||
| Inventory | 15.48M | ||
| Liabilities Non-Current | 15.53M | ||
| Trade and Non-Trade Payables | 18.57M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.33M | ||
| Net Cash Flow from Financing | -681.74K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.75M | ||
| Capital Expenditure | -1.07M | ||
| Net Cash Flow from Investing | -3.07M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -2.00M | ||
| Net Cash Flow from Operations | 3.02K | ||
| Share Based Compensation | 172.16K | ||
